- Home
- Products
NERLYNX (Neratinib)
NERLYNX (Neratinib)
- Medicine Name: NERLYNX
- Generic Name: Neratinib
- Dosage Form & Strength: 40 mg tablet (equivalent to 48.31 mg of Neratinib Meleate)
- Form: Oral Tablet
- Manufactured By:Puma Biotechnology, Inc.
- FDA Approval : Yes (2017)
NERLYNX is indicated as extended adjuvant therapy for adults with early-stage HER2-positive breast cancer, following treatment with trastuzumab-based (Herceptin) therapy.
It works by blocking HER2 receptors, which are responsible for the accelerated growth of certain breast cancer cells. NERLYNX helps reduce the risk of cancer recurrence after initial treatment.
- For patients with HER2-overexpressed/amplified early-stage breast cancer
- Administered after completion of adjuvant trastuzumab-based chemotherapy
Click here to download full prescribing information.
Documents required to import NERLYNX (Neratinib 40 mg) into India:
- Valid prescription from a licensed oncologist
- Patient’s diagnostic test reports
- Government-issued photo ID proof of the patient
Patients should verify the following before importing:
- Mode of import and shipping details
- Source verification, including supplier license and warehouse approvals
- Import-related paperwork, such as bill of entry and customs documentation
- Avoid cash transactions; use traceable methods of payment only
Availability in India:
NERLYNX is not approved by Indian drug authorities and is not commercially available through local distributors. However, patients can access the medication under the Named Patient Import program, subject to approval and legal compliance.
Global Rare Meds facilitates access in major cities including Mumbai, Delhi, Bangalore, Chennai, Hyderabad, Pune, Ahmedabad, Chandigarh, Lucknow, Jaipur, Noida, and others across India.
Global Rare Meds sources NERLYNX (Neratinib 40 mg) from verified international suppliers in the USA, Europe, and other regulatory-compliant regions.
Medication is dispatched from our fulfillment center in Ambernath, Thane District
All consignments are handled by licensed pharmacists
Delivery is available across India and internationally, following legal and regulatory norms
We ensure authentic product sourcing, documented shipping, and end-to-end transparency.
What is the generic name of NERLYNX?
The generic name is Neratinib.
Who manufactures NERLYNX?
NERLYNX is manufactured by Puma Biotechnology, Inc.
Is NERLYNX approved by the US FDA?
Yes, it was approved by the FDA in 2017.
What is the dosage form of NERLYNX?
It is available as 40 mg oral tablets.
What is the storage condition for NERLYNX?
Store at controlled room temperature: 20°C to 25°C; excursions between 15°C and 30°C are permitted.
How is NERLYNX supplied?
Available in packs of 126 or 180 tablets. Each tablet contains 40 mg Neratinib (equivalent to 48.31 mg of Neratinib Meleate).
Are generics or biosimilars of NERLYNX available?
No, there are no generic or biosimilar versions of NERLYNX available globally.
How do I get the price of NERLYNX in India?
Contact Global Rare Meds for pricing and availability:
Phone: +91-99675 15602
WhatsApp: +91-99675 15602
Email: info@globalraremeds.com
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
